Traumatic Brain Injuries Assessment Market Trends

Growth Drivers

• Developments in medical technology: Ongoing advancements in technology such as screening devices including computerized tomography (CT) scan, magnetic resonance imaging (MRI), and biomarker identification have enhanced the speed, accuracy, and convenience of TBI assessments. These technological developments enable healthcare professionals to diagnose TBIs more effectively which leads to better patient results and driving traumatic brain injuries assessment market growth. For example, In January 2024, the Wyss Institute for Biologically Inspired Engineering at Harvard University introduced a new brain imaging technique that allows the identification of mild traumatic brain injuries (mTBIs), otherwise undetectable by conventional techniques.
  
  Numerous TBIs can be treated with minimally invasive procedures such as ultrasound, MRI or CT scanning, and endoscopy to remove contusions that have formed from brain injury.  In March 2022, the Swoop Portable MR Imaging system was developed by UC Davis Health and Connecticut-based Hyperfine. It is the first portable MRI device approved by the Food and Drug Administration (FDA) and is designed to decrease the time for diagnosing traumatic brain injuries.
• Rise in campaigns and government initiatives to spread awareness about TBI: The rising number of campaigns and initiatives being undertaken by the governments of several countries about brain injuries are projected to fuel the traumatic brain injuries assessment market growth. The Brain Injury Association of America (BIAA) is focused on promoting public awareness through campaigns and initiatives to effectively treat TBIs and organizes a national public awareness campaign in March each year to highlight the importance of admitting the impact of brain injuries. For instance, in February 2024, BIAA announced a new awareness campaign in combination with brain injury awareness to involve and educate the general public.
  
  In November 2020, the decision-making body of WHO- the World Health Assembly passed resolution WHA73.10 and in 2021 it introduced the Decade for Action on Road Safety plan for global awareness of the treatment and assessment of neurological disorders. Ongoing observational studies conducted under the International Traumatic Brain Injury Research (InTBIR) initiative umbrella are pushing market adoption.

Challenges

• Complexity in classification and TBI diagnosis: TBIs vary widely in severity and can present with delayed or subtle symptoms while making diagnosis challenging assessing the extent of brain injury needs specialized equipment, training, and understanding of complex neurological data. This complexity can lead to under-diagnosis or misdiagnosis of TBIs particularly in mild cases by impacting patient outcomes.
• Ethical and regulatory concerns: Traumatic brain injury diagnostic devices particularly those involving data collection on brain function and neuroimaging face rigorous regulatory inspection. Compliance with strict healthcare regulations, ethical standards, and data privacy law can slow the approval and market entry of new TBI assessment innovations while increasing time to traumatic brain injuries assessment market and restricting modernization in certain regions.